26 November 2018 in Abdominal Radiology
7 October 2013 in Journal of Hepato-Biliary-Pancreatic Sciences
29 September 2021 in DEN Open
Objectives: Recently, a novel clip device, SureClip® (Micro‐Tech Co. Ltd., Nanjing, China), has been developed, which improved rotation and reopening performance. We aimed to assess the efficacy of the SureClip® in prophylactic closure of the mucosal break after endoscopic papillectomy (EP) for ampullary neoplasm.Methods: We retrospectively reviewed the medical records of 40 patients who underwent EP for ampullary neoplasms between October 2009 and March 2020. Prophylactic closure after resection was performed using the conventional clip between 2014 and 2018, and with the SureClip® after 2019. The baseline characteristics, techniques, outcomes, and complications of EP were analyzed.Results: The median age of the patients (25 males and 15 females) was 70 years. The en block resection rate was 82.5% and the curative resection rate was 80.0%. Histologically, 11 (27.5%) patients had malignancy. Prophylactic closure was performed in 29 (72.5%) patients (17 conventional clips, 12 SureClip®). Complications occurred in 18 (45.0%) patients, including postprocedure bleeding in 9 (22.5%) patients. However, no postprocedure bleeding was observed in the patients who received prophylactic closure using the SureClip® (p = 0.038). All other factors were not significantly correlated with postprocedure bleeding. The duration of hospital stay after EP was significantly shorter in patients treated with the SureClip® compared to those treated with a conventional clip or without clips (p < 0.05).Conclusions: In the present study, prophylactic clipping of the mucosal break using the SureClip® was effective in preventing bleeding after EP.
4 January 2023 in Endoscopy
Texture and color enhancement imaging (TXI) and red dichromatic imaging (RDI) modes are new image-enhancement options available on the EVIS X1 system (Olympus Corporation, Tokyo, Japan). TXI emphasizes slight differences in color tone and structural changes on the mucosal surface under normal light [1], whereas RDI may improve the visibility of deep blood vessels [2]. We previously reported the use of TXI- and RDI-mode cholangioscopy (CHF-B290, Olympus Corporation) in cholangiocarcinoma [3]. Here, we describe this technique in a patient with IgG4-related sclerosing cholangitis (IgG4-SC) and autoimmune pancreatitis (AIP). An 87-year-old woman presented with elevated liver enzymes and diffuse pancreatic enlargement ([Fig. 1], [Fig. 2]). Endoscopic retrograde cholangiopancreatography (ERCP) revealed segmental stenosis of the distal bile duct, preventing passage of the cholangioscope. A biliary stent was placed. Histopathology revealed no malignant findings; high IgG and IgG4 levels led to the diagnosis of AIP + IgG4-SC. Due to the patient’s age, stent replacement and stenosis reassessment were performed 2 months later without medication. The second ERCP showed slight improvement in stenosis, allowing passage of the cholangioscope. Cholangioscopy revealed partially dilated and slightly tortuous vessels without encasement or fusion [4] at the hilar bile duct. Dilated vessels were more clearly observed, and the fine surface structures of the thickened mucosa were more pronounced in TXI mode 1 than with white-light imaging. In RDI mode 3, the color of the bile disappeared and the dilated vessels were more strongly accentuated than with TXI. The mucosal surface was smooth, and no tumor vessels were observed at the stenosis ([Video 1]). The addition of TXI and RDI to cholangioscopy may therefore aid the diagnosis of IgG4-SC. A third ERCP 4 months later showed slight bile duct stenosis that did not require stenting; no adverse events or recurrence of symptoms were observed over the 10-month follow-up period. Video 1 Findings of the cholangioscopy using texture and color enhancement imaging mode 1 and red dichromatic imaging mode 3 in a patient with IgG4-related sclerosing cholangitis and autoimmune pancreatitis. Endoscopy_UCTN_Code_TTT_1AR_2AG Article published online: 30 August 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany